Menu
We are an Italian multinational, established in 1946, with a vocation to create solutions to meet new challenges in health and improve quality of life for people.
We have understood the regenerating potential of hyaluronic acid since the 1950s and today we are one of the leading global players in the manufacture of hyaluronic acid-based products. Full control of the supply chain, from research to marketing, sets us apart and for this reason we define ourselves as a fully integrated company.
We’re bringing our years of research and unique technologies to medical aesthetics in order to combine innovative protocols and applications involving proprietary hyaluronic acid-based products and autologous biological treatments. We offer both to practitioners and to patients, aesthetic solutions that preserve the person’s natural beauty and unique identity, consistent with scientific approach and guidelines of tissue engineering.
We study the effects of hyaluronic acid on the body and try to make it available where it is needed.
We produce pharmaceutical-grade hyaluronic acid, in a wide range of molecular weights and with peculiar chemical- physical characteristics, depending on the indications and the desired properties of finished product.
Today we have more than 1,300 international patents and our work has brought them to life in several therapeutic areas.
We market our products in Italy and abroad. For this reason, Fidia is periodically inspected by national and international regulatory authorities (AIFA, the Italian Ministry of Health, US FDA, Korean Ministry of Food and Drug Safety [KFDA], ANVISA Brazil, Pharmaceutical Inspectorate of the Ministry of Industry and Trade of the Russian Federation, UkrMedCert, UCA) and Notified Bodies (GMED, ISS, TUV, IMQ, Certiquality, Eurofins Biolab).
The regenerative power of Hyaluronic Acid
The regenerative power of Hyaluronic Acid
Nearly all biological effects of hyaluronan observed in vitro and in vivo systems depend on its molecular weight and its concentration.
Fidia’s approach in developing the Hyal-System Line lies in the Weight – Concentration – Technology (WCT) Concept, that is the unique combination of these three variables exploit different structural and biological properties of HA, enabling each Hyal-System Line product to bring out different targeted benefits.
BEAUTY STEMS FROM WITHIN
From the regenerating power of hyaluronic acid to the future of medicine
After decades of research into hyaluronic acid, which is known for its benefits in the natural repair and regeneration processes of damaged tissues, today we are also progressing in the field of regenerative medicine.
Regenerative medicine offers a promising synergistic role with hyaluronic acid, thanks to the development of new therapeutic strategies in the areas we work in. We have acquired and developed technologies to improve the availability of growth factors in tissues where there has been a loss in functionality as well as other systems associated with adipose tissue and its wide-ranging potential.
BEAUTY STEMS FROM WITHIN
February 1-3, 2024 | Palais des Congrès, Paris
Join us this January for this extraordinary 25th edition of IMCAS World Congress, and begin the new year among the best educators and innovators in medical aesthetics!
Visit Fidia booth N. Q208 | Level 2
Join our symposium on FEBRUARY 3RD | 2-3.30 PM | ROOM 351 –LEVEL 3
March 27-29, 2024 | Grimaldi Forum, Monte-Carlo
© Fidia Farmaceutici S.p.A.
Via Ponte della Fabbrica 3/A – 35031 Abano Terme (PD) – Italy
Tel. (+39) 049 8232222 Fax (+39) 049 810653
Cap. Soc. € 36.120.000 int. vers. – C.C.I.A.A. PD n. 80793 – Iscr. Reg. Imp. PD
Cod. Fisc. e P. IVA 00204260285
OUR KNOW-HOW
Powered by Ideandum
To access this page, please click YES if you are a healthcare professional.
If you are not a healthcare professional, select NO to exit.